In this episode, BYU Tech Transfer interns speak with Chad Pollard, a BYU PhD student and entrepreneur whose groundbreaking diagnostic technology aims to revolutionize Alzheimer’s detection. Chad shares how his research, initially focused on Alzheimer’s, expanded to include diagnostics for other neurodegenerative diseases like Parkinson’s and ALS. Through partnerships, venture funding, and a team of experienced mentors, Chad’s startup has grown rapidly, securing a $114 million valuation. This episode is ideal for STEM students, researchers, and aspiring entrepreneurs looking to learn about the path from academic research to successful tech commercialization and the value of building a supportive network.